Pfizer
I attained my bachelor’s degree in Biochemistry from The University of Ghana.
I also hold a master’s degree in Physiology from Dongguk University in South Korea. I started my PhD studies at Virginia Commonwealth University with a focus on Medicinal Chemistry, but later transferred to University of Houston where I pivoted to Pharmaceutical Science with special focus on formulation development and pharmacokinetic assessment of a novel combination of anti-neoplastic and tumor stroma modulating agents for the treatment of pancreatic cancer.
While in graduate school I completed two internships at Gilead Sciences and then later at Pfizer. After graduation in May 2021, I joined Pfizer Clinical Pharmacology where I am supporting early and late clinical development of various compounds for the treatment of cancer.
Disclosure information not submitted.
Thursday, March 17, 2022
4:40 PM – 4:55 PM ET
.png)